摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-methoxyphenyl)-3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydroindazole | 51300-52-8

中文名称
——
中文别名
——
英文名称
1-(4-methoxyphenyl)-3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydroindazole
英文别名
1-(4-methoxyphenyl)-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one;3,6,6-Trimethyl-4-oxo-1-(p-methoxyphenyl)-4,5,6,7-tetrahydroindazol;1-(4-methoxy-phenyl)-3,6,6-trimethyl-1,5,6,7-tetrahydro-indazol-4-one;1-(4-Methoxyphenyl)-3,6,6-trimethyl-5,7-dihydroindazol-4-one
1-(4-methoxyphenyl)-3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydroindazole化学式
CAS
51300-52-8
化学式
C17H20N2O2
mdl
——
分子量
284.358
InChiKey
SIEMMYUIIJKHLU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    21
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    44.1
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    2-乙酰基-5,5-二甲基-1,3-环己二酮4-甲氧基苯肼盐酸盐盐酸 作用下, 以 乙醇 为溶剂, 反应 5.0h, 以40%的产率得到1-(4-methoxyphenyl)-3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydroindazole
    参考文献:
    名称:
    Discovery, structure–activity relationship studies, and anti-nociceptive effects of 1-phenyl-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one as novel opioid receptor agonists
    摘要:
    The μ-opioid receptor (MOR) is the major opioid receptor targeted by most analgesics in clinical use. However, the use of all known MOR agonists is associated with severe adverse effects. We reported that the 1-phenyl-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-ones are novel opioid receptor agonists. Subsequent structural modification resulted in the potent MOR/KOR (κ-opioid receptor) agonists 19, 20, and 21. Testing the analgesic effect of these in WT B6 mice (tail-flick test) gave ED50 values of 8.4, 10.9, and 26.6mg/kg, respectively. The 1-phenyl-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one core could be addressed in 1 or 2 synthetic steps with moderate to high percent of yield. In the adenylyl cyclase assay, compound 19 displayed a MOR/KOR agonist profile, with IC50 values of 0.73 and 0.41μM, respectively. Current results suggest that compound 19 is a promising lead to go further development and in vitro/in vivo adverse effects studies.
    DOI:
    10.1016/j.bmc.2014.07.012
点击查看最新优质反应信息

文献信息

  • 1-(1-Phthalazinyl)- and 1-(4methoxyphenyl)-6,6dimethyl-4oxo-4,5,6,7-tetrahydroindazole
    作者:A. Ya. Strakov、I. A. Strakova、M. V. Petrova
    DOI:10.1007/bf01164795
    日期:1996.5
查看更多